172 related articles for article (PubMed ID: 15172782)
21. Tobacco industry strategies for influencing European Community tobacco advertising legislation.
Neuman M; Bitton A; Glantz S
Lancet; 2002 Apr; 359(9314):1323-30. PubMed ID: 11965294
[TBL] [Abstract][Full Text] [Related]
22. Tobacco industry strategies to undermine the 8th World Conference on Tobacco or Health.
Muggli ME; Hurt RD
Tob Control; 2003 Jun; 12(2):195-202. PubMed ID: 12773731
[TBL] [Abstract][Full Text] [Related]
23. Looking inside the tobacco industry: revealing insights from the Guildford Depository.
Lee K; Gilmore AB; Collin J
Addiction; 2004 Apr; 99(4):394-7. PubMed ID: 15049733
[No Abstract] [Full Text] [Related]
24. Turning free speech into corporate speech: Philip Morris' efforts to influence U.S. and European journalists regarding the U.S. EPA report on secondhand smoke.
Muggli ME; Hurt RD; Becker LB
Prev Med; 2004 Sep; 39(3):568-80. PubMed ID: 15313097
[TBL] [Abstract][Full Text] [Related]
25. Turning a threat into an opportunity: British American Tobacco's weakening of the Protocol to Eliminate Illicit Trade in Tobacco Products.
Gomis B; Gallagher AWA; Rowell A; Gilmore AB
Tob Control; 2022 Jan; 31(1):40-49. PubMed ID: 34531314
[TBL] [Abstract][Full Text] [Related]
26. "Almost a role model of what we would like to do everywhere": British American Tobacco in Cambodia.
MacKenzie R; Collin J; Sopharo C; Sopheap Y
Tob Control; 2004 Dec; 13 Suppl 2(Suppl 2):ii112-7. PubMed ID: 15564213
[TBL] [Abstract][Full Text] [Related]
27. The p53 tumour suppressor gene and the tobacco industry: research, debate, and conflict of interest.
Bitton A; Neuman MD; Barnoya J; Glantz SA
Lancet; 2005 Feb 5-11; 365(9458):531-40. PubMed ID: 15705463
[TBL] [Abstract][Full Text] [Related]
28. Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry.
Iida K; Proctor RN
Lancet; 2004 May; 363(9423):1820-4. PubMed ID: 15172783
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of the third wave of tobacco litigation in the United States, 1994-2005.
Douglas CE; Davis RM; Beasley JK
Tob Control; 2006 Dec; 15 Suppl 4(Suppl 4):iv9-16. PubMed ID: 17130629
[TBL] [Abstract][Full Text] [Related]
30. Moving East: how the transnational tobacco industry gained entry to the emerging markets of the former Soviet Union-part I: establishing cigarette imports.
Gilmore AB; McKee M
Tob Control; 2004 Jun; 13(2):143-50. PubMed ID: 15175531
[TBL] [Abstract][Full Text] [Related]
31. Looking through a keyhole at the tobacco industry. The Brown and Williamson documents.
Glantz SA; Barnes DE; Bero L; Hanauer P; Slade J
JAMA; 1995 Jul; 274(3):219-24. PubMed ID: 7609230
[TBL] [Abstract][Full Text] [Related]
32. British American Tobacco's partnership with Earthwatch Europe and its implications for public health.
McDaniel PA; Malone RE
Glob Public Health; 2012; 7(1):14-28. PubMed ID: 21347934
[TBL] [Abstract][Full Text] [Related]
33. Tobacco control implications of the first European product liability suit.
Hiilamo HT
Tob Control; 2005 Feb; 14(1):22-30. PubMed ID: 15735296
[TBL] [Abstract][Full Text] [Related]
34. 'A preferred consultant and partner to the Royal Government, NGOs, and the community': British American Tobacco's access to policy-makers in Cambodia.
MacKenzie R; Collin J
Glob Public Health; 2017 Apr; 12(4):432-448. PubMed ID: 27079136
[TBL] [Abstract][Full Text] [Related]
35. 'A major lobbying effort to change and unify the excise structure in six Central American countries': How British American Tobacco influenced tax and tariff rates in the Central American Common Market.
Holden C; Lee K
Global Health; 2011 May; 7():15. PubMed ID: 21595921
[TBL] [Abstract][Full Text] [Related]
36. Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents.
Drope J; Chapman S
J Epidemiol Community Health; 2001 Aug; 55(8):588-94. PubMed ID: 11449018
[TBL] [Abstract][Full Text] [Related]
37. Secret science: tobacco industry research on smoking behaviour and cigarette toxicity.
Hammond D; Collishaw NE; Callard C
Lancet; 2006 Mar; 367(9512):781-7. PubMed ID: 16517278
[TBL] [Abstract][Full Text] [Related]
38. Open doorway to truth: legacy of the Minnesota tobacco trial.
Hurt RD; Ebbert JO; Muggli ME; Lockhart NJ; Robertson CR
Mayo Clin Proc; 2009 May; 84(5):446-56. PubMed ID: 19411441
[TBL] [Abstract][Full Text] [Related]
39. Through tobacco industry eyes: civil society and the FCTC process from Philip Morris and British American Tobacco's perspectives.
Gonzalez M; Green LW; Glantz SA
Tob Control; 2012 Jul; 21(4):e1. PubMed ID: 21636611
[TBL] [Abstract][Full Text] [Related]
40. Gaining access to Vietnam's cigarette market: British American Tobacco's strategy to enter 'a huge market which will become enormous'.
Lee K; Kinh HV; Mackenzie R; Gilmore AB; Minh NT; Collin J
Glob Public Health; 2008; 3(1):1-25. PubMed ID: 19288356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
